CTXR Citius Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$0,53
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,4752 haftanın en düşüğü
$2,1952 haftanın en yükseği
Piyasa Değeri (MRQ)
$15M
P/E
-0.4
Hisse Başına Kâr
$-3.38
rozetleriniz
52 Haftlık Aralık
$0–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$4
P/E
-0.4
ROE
·
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CTXR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.53
Piyasa Değeri (MRQ)
$15M
P/E
-0.4
Hisse Başına Kâr
$-3.38
52 Haftlık Aralık
$0–$2
CTXR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 26 Kasım 2024 | 1-for-25 | Ters |
| 09 Haziran 2017 | 1-for-15 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-3.382021-09-30 → 2025-09-30
Serbest Nakit Akışı·2020-09-30 → 2021-09-30
Net kar marjı·2016-09-30 → 2016-09-30
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CTXR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.45Y ort. ≈-71.5 | ≈-71.5 | · | · | |
| F/D (MRQ) | 0.25Y ort. ≈43.0 | ≈43.0 | 1.5 | Düşük değerli | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.45Y ort. ≈28.6 | ≈28.6 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CTXR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 0.85Y ort. ≈11.4 | ≈11.4 | 4.4 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-106.0%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Eylül 2025 | $-0.72 | $-0.50 | -45.0% | |
| 30 Haziran 2025 | $-0.80 | $-0.60 | -32.9% | |
| 31 Mart 2025 | $-1.27 | $-0.39 | -224.8% | |
| 31 Aralık 2024 | $-1.30 | $-0.59 | -121.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | · | · | · | · | · | · | · | $75.0K | $50.0K | $45.0K | · | · | |
| R&D Expense | $9M | $12M | $15M | $18M | $12M | $9M | $9M | $7M | $3M | $3M | $2M | $574 | |
| SG&A Expense | $19M | $18M | $15M | $12M | $10M | $8M | $6M | $6M | $6M | $4M | $946.6K | $183.0K | |
| Operating Expenses | $39M | $42M | $37M | $33M | $24M | $18M | $16M | $14M | $10M | $7M | $3M | $653.8K | |
| Operating Income | $-39M | $-42M | $-37M | $-33M | $-24M | $-18M | $-16M | $-14M | $-10M | $-7M | $-3M | $-653.8K | |
| Interest Expense | · | · | · | · | $10.8K | $15.7K | $16.4K | $15.8K | $850.8K | $9.0K | $7.5K | $93.1K | |
| Interest Income | $110.1K | $758.0K | $1M | $251.4K | $261.8K | $68.1K | $52.7K | · | · | $806 | · | · | |
| Other Non-op | $-157.7K | $3M | $5M | $251.4K | $477.5K | $162.6K | $36.2K | $1M | $-398.6K | $-846.4K | $348.0K | · | |
| Pretax Income | $-39M | $-39M | $-32M | $-33M | $-23M | $-18M | $-16M | $13M | $10M | $-8M | $-3M | $-737.7K | |
| Income Tax | $1M | $576.0K | $576.0K | $576.0K | $1.2K | $741 | · | · | · | · | · | · | |
| Net Income | $-40M | $-39M | $-33M | $-34M | $-23M | $-18M | $-16M | $-13M | $-10M | $-8M | $-3M | $-737.7K | |
| EPS (Basic) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | · | · | · | · | · | · | · | |
| Shares (Basic) | 11,065,225 | 6,726,999 | 6,051,789 | 146,082,399 | 108,599,080 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 11,065,225 | 6,726,999 | 6,051,789 | 146,082,399 | 108,599,080 | · | · | · | · | · | · | · | |
| EBITDA | · | · | $-37M | $-33M | $-24M | $-18M | $-16M | $-14M | · | $-7M | $-3M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $26M | $42M | $70M | $14M | $8M | $9M | $3M | $294.4K | $676.1K | $2M | |
| Inventory | $22M | $8M | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $3M | $8M | $3M | $3M | $122.2K | $48.1K | $57.7K | $220.2K | $598.5K | $60.0K | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $19M | · | · | |
| Current Assets | $28M | $14M | $34M | $45M | $73M | $14M | $8M | $10M | $3M | $892.8K | $736.1K | $2M | |
| PP&E (Net) | · | · | $1.4K | $4.1K | $7.0K | $1.6K | $590 | $1.5K | $3.2K | $3.7K | · | · | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $8.5K | · | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | $4.8K | · | · | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $2M | $2M | $2M | · | · | |
| Other Non-current Assets | $102M | $102M | $69M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $131M | $117M | $104M | $114M | $142M | $44M | $37M | $31M | $24M | $22M | $741.5K | $2M | |
| Accounts Payable | $14M | $5M | $3M | $1M | $1M | $2M | $3M | $2M | $602.4K | $909.2K | $559.1K | $106.2K | |
| Accrued Liabilities | $4M | $17.0K | $476.3K | $1M | $622.0K | $164.0K | $246.2K | $181.7K | $560.9K | $958.1K | $8.3K | $60.3K | |
| Short-term Debt | $1M | · | · | · | · | $173.0K | $173.0K | $173.0K | $173.0K | $673.0K | · | · | |
| Current Liabilities | $45M | $36M | $6M | $5M | $4M | $4M | $5M | $3M | $2M | $5M | $1M | $2M | |
| Capital Leases | $724.9K | $21.3K | $262.9K | $481.2K | $678.2K | $855.5K | · | · | · | · | · | · | |
| Deferred Tax | $8M | $7M | $6M | $6M | $5M | $5M | $5M | · | · | · | · | · | |
| Total Liabilities | $53M | $43M | $12M | $11M | $10M | $10M | $10M | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | $173.0K | $173.0K | $173.0K | · | · | · | · | |
| Common Stock | $18.1K | $7.2K | $6.4K | $146.2K | $146.0K | $55.6K | $28.9K | $16.2K | $8.3K | $4.9K | $34.1K | $30.0K | |
| Paid-in Capital | $306M | $271M | $253M | $232M | $228M | $104M | $80M | $68M | $50M | $34M | $8M | $5M | |
| Retained Earnings | $-239M | $-201M | $-162M | $-130M | $-96M | $-71M | $-53M | $-40M | $-28M | $-17M | $-9M | $-6M | |
| Stockholders' Equity | $68M | $70M | $91M | $103M | $132M | $34M | $27M | $31M | $22M | $17M | $-635.2K | $-741.9K | |
| Liabilities + Equity | $131M | $117M | $104M | $114M | $142M | $44M | $37M | $31M | $24M | $22M | $741.5K | $2M | |
| Shares Outstanding | 18,067,744 | 7,247,243 | 6,354,371 | 146,211,130 | 145,979,429 | 55,576,996 | 28,930,493 | 16,198,791 | 8,345,844 | 4,875,871 | 34,117,886 | 30,025,295 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $12M | $7M | $4M | $1M | $803.3K | $716.0K | $779.7K | $986.6K | $732.2K | $732.2K | $470.2K | |
| Deferred Tax | $1M | $576.0K | $576.0K | $576.0K | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-27M | $-28M | $-29M | $-28M | $-24M | $-17M | $-12M | $-11M | $-8M | $-6M | $-2M | $-183.2K | |
| CapEx | · | · | · | · | $6.9K | $1.8K | · | · | $2.1K | · | · | · | |
| Investing Cash Flow | $-6M | $-5M | · | · | $-40M | $-1.8K | · | · | $-2.1K | $255.7K | · | · | |
| Stock Issued | $32M | $14M | · | · | $500 | · | · | · | · | · | · | $50.0K | |
| Net Stock Activity | · | · | · | · | $82.6K | · | · | · | · | · | · | · | |
| Financing Cash Flow | $33M | $10M | $14M | · | $120M | $23M | $11M | $17M | $11M | $5M | $2M | $2M | |
| Net Change in Cash | · | · | · | · | · | · | $-1M | $6M | $3M | $-381.8K | $-875.9K | $1M | |
| Free Cash Flow | · | · | · | · | $-24M | $-17M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -924229.7% | -105346.7% | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | -1029242.9% | -94659.8% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | -1029242.9% | -94659.8% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -924229.7% | -105346.7% | · | |
| ROA | · | · | -29.9% | -26.2% | -24.8% | -43.6% | -51.8% | -45.2% | · | -73.1% | -252.5% | · | |
| ROE | · | · | -33.6% | -28.6% | -27.8% | -59.6% | -64.0% | -50.6% | · | -102.8% | 421.5% | · | |
| ROIC | · | · | -41.2% | -33.0% | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 5.9 | 9.8 | 18.3 | 3.4 | 1.7 | 3.2 | · | 0.2 | 0.5 | · | |
| Quick Ratio | · | · | 4.6 | 9.2 | 17.6 | 3.4 | 1.7 | 2.9 | · | 0.1 | 0.5 | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | -2171.0 | -1130.0 | -948.6 | -870.6 | · | -828.3 | -430.7 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $0.57 | $0.70 | $0.91 | $0.61 | $0.84 | $1.72 | · | $0.23 | $-0.02 | · | |
| Cash Flow / Share | · | · | $-0.19 | $-0.19 | · | · | · | · | · | · | · | · | |
| Cash / Share | · | · | $0.17 | $0.29 | $0.48 | $0.25 | $0.27 | $0.57 | · | $0.00 | $0.02 | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | $0.60 | · | · | |
| EPS (TTM) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-40M | $-39M | $-33M | $-34M | $-23M | $-18M | $-16M | $-13M | $-10M | $-8M | $-3M | · | |
| Market Cap | · | · | $2.72B | $4.42B | $7.41B | $1.45B | $548M | $692M | · | $17.28B | $21.75B | · | |
| Enterprise Value | · | · | · | · | · | $1.43B | $541M | $683M | · | · | · | · | |
| P/E | -0.4 | -2.1 | -3.1 | -131.5 | -220.7 | · | · | · | · | · | · | · | |
| P/B | · | · | 29.9 | 43.0 | 56.0 | 42.9 | 22.5 | 24.9 | · | 1030.6 | -34240.7 | · | |
| P / Tangible Book | 0.4 | 1.5 | 33.3 | 47.3 | 60.3 | 59.4 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | -93.5 | -155.9 | -305.5 | -85.3 | -44.1 | -61.2 | · | -2928.4 | -9118.0 | · | |
| P / FCF | · | · | · | · | -305.4 | -85.3 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | -80.8 | -34.7 | -49.6 | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -84.5 | · | · | · | · | · | · | |
| Earnings Yield | -272.6% | -47.7% | -32.6% | -0.76% | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · |
Gelir Tablosu
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cost of Revenue | $491.8K | $328.9K | $789.2K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | $1M | $1M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $1M | $2M | $2M | $2M | $2M | $4M | $2M | $3M | $3M | $4M | $3M | $3M | $4M | $5M | $3M | $4M | |
| SG&A Expense | $6M | $26M | $6M | $4M | $4M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | $3M | $3M | |
| Operating Expenses | $13M | $34M | $12M | $8M | $9M | $11M | $10M | $11M | $11M | $11M | $9M | $10M | $9M | $11M | $7M | $8M | |
| Operating Income | $-12M | $-32M | $-9M | $-8M | $-9M | $-11M | $-10M | $-11M | $-11M | $-11M | $-9M | $-10M | $-9M | $-11M | $-7M | $-8M | |
| Interest Expense | $198.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | $116.7K | $53.6K | $45.1K | $53.4K | $20.6K | $13.4K | $22.6K | $117.3K | $204.8K | $182.2K | $253.6K | $324.8K | $336.8K | $303.3K | $214.5K | $134.8K | |
| Other Non-op | $-294.5K | $4M | $-110.4K | $-42.1K | $-151.6K | $13.4K | $22.6K | $117.3K | $204.8K | $3M | $253.6K | $324.8K | $336.8K | $303.3K | $4M | · | |
| Pretax Income | $-12M | $-28M | $-9M | $-8M | $-9M | $-11M | $-10M | $-11M | $-10M | $-8M | $-9M | $-10M | $-8M | $-10M | $-3M | $-7M | |
| Income Tax | $-107.3K | $-231.2K | $264.2K | $264.2K | $264.2K | $264.2K | $264.2K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | · | |
| Net Income | $-12M | $-28M | $-9M | $-9M | $-9M | $-12M | $-10M | $-11M | $-11M | $-9M | $-9M | $-10M | $-8M | $-11M | $-4M | $-8M | |
| EPS (Basic) | $-0.34 | $-0.95 | $-0.38 | $-0.01 | $-0.80 | $-1.27 | $-1.30 | $-1.61 | $-1.57 | $-1.34 | $-1.45 | $-5.42 | $-0.06 | $-0.07 | $-0.02 | · | |
| EPS (Diluted) | $-0.34 | $-0.95 | $-0.38 | $-0.01 | $-0.80 | $-1.27 | $-1.30 | $-1.61 | $-1.57 | $-1.34 | $-1.45 | $-5.42 | $-0.06 | $-0.07 | $-0.02 | · | |
| Shares (Basic) | 26,169,589 | 22,376,427 | 21,495,274 | · | 11,006,896 | 8,581,207 | 7,492,460 | · | 6,954,278 | 6,362,890 | 6,358,237 | · | 153,775,380 | 146,251,945 | 146,211,130 | · | |
| Shares (Diluted) | 26,169,589 | 22,376,427 | 21,495,274 | · | 11,006,896 | 8,581,207 | 7,492,460 | · | 6,954,278 | 6,362,890 | 6,358,237 | · | 153,775,380 | 146,251,945 | 146,211,130 | · | |
| EBITDA | $-12M | $-32M | $-9M | · | $-9M | $-11M | $-10M | · | $-11M | $-11M | $-9M | · | $-9M | $-11M | $-7M | · |
Bilanço
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $5M | $8M | $4M | $6M | $26.4K | $1M | $3M | $18M | $13M | $20M | $26M | $33M | $29M | $37M | $42M | |
| Receivables | $686.2K | $1M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $23M | $23M | $23M | $22M | $17M | $15M | $14M | $8M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $1M | $1M | $3M | $3M | $3M | $10M | $9M | $8M | $8M | $8M | $6M | $5M | $3M | |
| Current Assets | $43M | $32M | $38M | $28M | $25M | $18M | $18M | $14M | $28M | $22M | $28M | $34M | $41M | $35M | $42M | $45M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $275 | $854 | $1.4K | $2.0K | $2.6K | $3.4K | $4.1K | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $98M | $100M | $102M | $102M | $102M | $102M | $102M | $102M | · | · | · | $69M | · | · | · | · | |
| Total Assets | $142M | $133M | $140M | $131M | $128M | $121M | $121M | $117M | $97M | $91M | $97M | $104M | $110M | $104M | $112M | $114M | |
| Accounts Payable | $8M | $9M | $11M | $14M | $10M | $9M | $7M | $5M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $26M | $24M | $5M | $4M | $9M | $9M | $6M | $17.0K | $550.5K | $151.2K | $276.9K | $476.3K | $892.9K | $2M | $690.4K | $1M | |
| Short-term Debt | · | · | $1M | $1M | $1M | $300M | $300M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $52M | $55M | $38M | $45M | $52M | $50M | $45M | $36M | $4M | $4M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Capital Leases | $590.8K | $636.7K | $681.6K | $724.9K | $767.0K | $786.7K | · | $21.3K | $84.4K | $145.1K | $204.6K | $262.9K | $320.0K | $374.8K | $428.6K | $481.2K | |
| Deferred Tax | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Total Liabilities | $66M | $63M | $47M | $53M | $60M | $58M | $52M | $43M | $11M | $11M | $12M | $12M | $12M | $12M | $11M | $11M | |
| Total Debt | · | · | $1M | · | $1M | $300M | $300M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $27.5K | $22.4K | $22.4K | $18.1K | $14.5K | $8.8K | $7.7K | $7.2K | $180.7K | $159.1K | $159.0K | $6.4K | $158.9K | $146.4K | $146.2K | $146.2K | |
| Paid-in Capital | $344M | $330M | $327M | $306M | $296M | $283M | $277M | $271M | $276M | $259M | $256M | $253M | $250M | $235M | $234M | $232M | |
| Retained Earnings | $-277M | $-268M | $-247M | $-239M | $-231M | $-222M | $-211M | $-201M | $-191M | $-180M | $-171M | $-162M | $-152M | $-144M | $-133M | $-130M | |
| Stockholders' Equity | $67M | $62M | $80M | $68M | $65M | $61M | $65M | $70M | $86M | $79M | $85M | $91M | $98M | $91M | $100M | $103M | |
| Liabilities + Equity | $142M | $133M | $140M | $131M | $128M | $121M | $121M | $117M | $97M | $91M | $97M | $104M | $110M | $104M | $112M | $114M | |
| Shares Outstanding | 27,452,570 | 22,376,427 | 22,376,427 | 18,067,744 | 14,475,029 | 8,760,649 | 7,727,243 | 7,247,243 | 180,725,407 | 159,094,781 | 158,966,576 | 6,354,371 | 158,857,798 | 146,357,797 | 146,211,130 | 146,211,130 |
Nakit Akışı
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $1M | $1M | $1M | $976.7K | |
| Deferred Tax | $-107.3K | $-231.2K | $264.2K | $264.2K | $264.2K | $264.2K | $264.2K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | · | |
| Operating Cash Flow | $-9M | $-1M | $-13M | $-12M | $-5M | $-5M | $-5M | $-6M | $-8M | $-8M | $-6M | $-7M | $-10M | $-8M | $-5M | $-6M | |
| Investing Cash Flow | $-2M | $-600.0K | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $4M | $-62.8K | $21M | $16M | $10M | $3M | $3M | $84.7K | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $21M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $23M | $-1M | $21M | $16M | $11M | $3M | $3M | $-4M | · | · | · | $-687 | $14M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 80.3% | 80.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -785.4% | -1931.0% | -228.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -797.9% | -1686.0% | -238.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -805.1% | -1699.8% | -231.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -785.4% | -1931.0% | -228.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -8.8% | -22.1% | -7.2% | · | -8.2% | -10.8% | -9.4% | · | -10.2% | -8.8% | -8.8% | · | -7.3% | -9.1% | -2.9% | · | |
| ROE | -18.1% | -46.0% | -12.9% | · | -12.2% | -16.4% | -13.7% | · | -11.5% | -10.0% | -10.0% | · | -8.2% | -10.1% | -3.2% | · | |
| ROIC | -17.5% | -51.9% | -11.5% | · | -13.7% | -3.2% | -2.8% | · | -12.6% | -14.1% | -11.2% | · | -9.0% | -11.9% | -7.5% | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.6 | 1.0 | · | 0.5 | 0.4 | 0.4 | · | 6.7 | 5.2 | 5.1 | · | 7.1 | 5.6 | 9.3 | · | |
| Quick Ratio | 0.3 | 0.1 | 0.3 | · | 0.1 | 0.0 | 0.0 | · | 4.3 | 3.0 | 3.6 | · | 5.7 | 4.7 | 8.1 | · | |
| Debt / Equity | · | · | 0.0 | · | 0.0 | 4.9 | 4.6 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -59.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory Turnover | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.4 | 3.1 | 1.9 | · | · | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.43 | $2.75 | $3.57 | · | $4.49 | $6.92 | $8.46 | · | $0.47 | $0.50 | $0.53 | · | $0.61 | $0.62 | $0.69 | · | |
| Revenue / Share | $0.06 | $0.07 | $0.18 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | $-0.61 | · | · | · | $-0.63 | · | · | · | $-0.04 | · | · | · | $-0.03 | · | |
| Cash / Share | $0.62 | $0.21 | $0.35 | · | $0.42 | $0.00 | $0.14 | · | $0.10 | $0.08 | $0.13 | · | $0.21 | $0.20 | $0.25 | · | |
| EPS (TTM) | $-1.68 | $-2.14 | $-2.46 | · | $-4.98 | $-5.75 | $-5.82 | · | $-9.78 | $-8.27 | $-7.00 | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | |
| Net Income TTM | $-58M | $-55M | $-39M | · | $-42M | $-43M | $-40M | · | $-38M | $-36M | $-38M | · | $-31M | $-31M | $-28M | · | |
| Market Cap | $17M | $20M | $17M | · | $23M | $13M | $31M | · | $2.64B | $3.57B | $3.01B | · | $4.77B | $4.28B | $2.89B | · | |
| Enterprise Value | · | · | $11M | · | $18M | $313M | $330M | · | · | · | · | · | · | · | · | · | |
| P/E | -0.4 | -0.4 | -0.3 | · | -0.3 | -0.3 | -0.7 | · | -1.5 | -2.7 | -2.7 | · | · | · | · | · | |
| P/B | 0.2 | 0.3 | 0.2 | · | 0.4 | 0.2 | 0.5 | · | 30.8 | 45.0 | 35.5 | · | 48.8 | 46.9 | 28.8 | · | |
| P / Tangible Book | 0.3 | 0.4 | 0.2 | · | 0.4 | 0.3 | 0.6 | · | 34.6 | 51.0 | 39.9 | · | 53.9 | 52.3 | 31.7 | · | |
| P / Cash Flow | · | · | -1.3 | · | · | · | -6.5 | · | · | · | -490.3 | · | · | · | -598.6 | · | |
| Earnings Yield | -277.7% | -237.8% | -316.6% | · | -313.2% | -385.9% | -145.5% | · | -67.0% | -36.9% | -37.0% | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Net Gelir | $-40M | $-39M | $-33M | $-34M | $-23M |
| Seyreltilmiş Hisse Başı Kâr | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 |
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Cari Oran | · | · | 5.9 | 9.8 | 18.3 |
| Cari Oran | · | · | 4.6 | 9.2 | 17.6 |
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | · | · | $-24M |
Kurumsal Sahipler (13F) 43 dosya · $964K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
43
Tutulan Değer
$964K
Yeni pozisyonlar
12
Çıkan pozisyonlar
8
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 12 (+2 önceki Ç'ye göre) | 8 (-1 önceki Ç'ye göre) | 8 (+1 önceki Ç'ye göre) | 9 (+2 önceki Ç'ye göre) | +310K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $154.824 | 199.258 | 16,06% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $130.302 | 215.537 | 13,51% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $119.405 | 197.364 | 12,38% | Hisse senetleri |
| Miller Financial Services LLC | $78.585 | 130.000 | 8,15% | Hisse senetleri |
| CITADEL ADVISORS LLC | $75.508 | 124.910 | 7,83% | Hisse senetleri |
| JANE STREET GROUP, LLC | $74.255 | 122.837 | 7,70% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $47.042 | 77.755 | 4,88% | Hisse senetleri |
| BlackRock, Inc. | $42.224 | 69.850 | 4,38% | Hisse senetleri |
| NORTHERN TRUST CORP | $37.928 | 62.742 | 3,93% | Hisse senetleri |
| XTX Topco Ltd | $35.786 | 59.199 | 3,71% | Hisse senetleri |
| Asset Advisory Group, Inc. | $35.672 | 59.011 | 3,70% | Hisse senetleri |
| BostonPremier Wealth LLC | $16.926 | 28.000 | 1,76% | Hisse senetleri |
| UBS Group AG | $15.933 | 26.335 | 1,65% | Hisse senetleri |
| LPL Financial LLC | $15.381 | 25.445 | 1,60% | Hisse senetleri |
| STATE STREET CORP | $14.067 | 23.271 | 1,46% | Hisse senetleri |
| Arkadios Wealth Advisors | $12.090 | 20.000 | 1,25% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $10.575 | 17.494 | 1,10% | Hisse senetleri |
| Sanctuary Advisors, LLC | $7.139 | 11.810 | 0,74% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.130 | 11.795 | 0,74% | Hisse senetleri |
| R Squared Ltd | $6.670 | 11.033 | 0,69% | Hisse senetleri |
| TWO SIGMA SECURITIES, LLC | $6.049 | 10.006 | 0,63% | Hisse senetleri |
| SBI Securities Co., Ltd. | $5.754 | 9.519 | 0,60% | Hisse senetleri |
| CHELSEA COUNSEL CO | $2.797 | 4.626 | 0,29% | Hisse senetleri |
| Quent Capital, LLC | $2.558 | 4.232 | 0,27% | Hisse senetleri |
| IFP Advisors, Inc | $2.529 | 4.183 | 0,26% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $1.647 | 2.724 | 0,17% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $1.543 | 2.575 | 0,16% | Hisse senetleri |
| GROUP ONE TRADING LLC | $938 | 1.551 | 0,10% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $759 | 1.256 | 0,08% | Hisse senetleri |
| BARCLAYS PLC | $663 | 1.096 | 0,07% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $605 | 1.000 | 0,06% | Hisse senetleri |
| Luminist Capital LLC | $263 | 435 | 0,03% | Hisse senetleri |
| ASSETMARK, INC | $225 | 372 | 0,02% | Hisse senetleri |
| Princeton Global Asset Management LLC | $97 | 160 | 0,01% | Hisse senetleri |
| Smallwood Wealth Investment Management, LLC | $72 | 120 | 0,01% | Hisse senetleri |
| JPMORGAN CHASE & CO | $69 | 120 | 0,01% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $65 | 107 | 0,01% | Hisse senetleri |
| Arax Advisory Partners | $51 | 84 | 0,01% | Hisse senetleri |
| Federation des caisses Desjardins du Quebec | $48 | 80 | 0,00% | Hisse senetleri |
| MORGAN STANLEY | $27 | 44 | 0,00% | Hisse senetleri |
| Fairscale Capital, LLC | $25 | 42 | 0,00% | Hisse senetleri |
| Virtu Financial LLC | $13 | 20.836 | 0,00% | Hisse senetleri |
| Bogart Wealth, LLC | $2 | 4 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Leonard L. Mazur ×3 başvurular | 27 Kasım 2024 | · | İlk başvuru | · | SEC |
| Myron Z. Holubiak ×2 başvurular | 18 Şubat 2022 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 11 içeriden öğrenenler · 4 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Leonard L Mazur | Chief Executive Officer | 08 Ağustos 2025 A | 10.255.343 | 0 | 0 | $0 |
| Jaime Bartushak | Chief Financial Officer | 07 Kasım 2024 A | · | 0 | 0 | $0 |
| Myron Z Holubiak | Vice Chairman | 08 Ağustos 2025 A | 1.992.243 | 0 | 0 | $0 |
| Myron Czuczman | Chief Medical Officer | 07 Kasım 2024 A | · | 0 | 0 | $0 |
| Robert Joseph Smith | Yönetim kurulu üyesi | 07 Kasım 2024 A | · | 0 | 0 | $0 |
| Eugene Myron Holuka | Yönetim kurulu üyesi | 07 Kasım 2024 A | 2.367 | 0 | 0 | $0 |
| Carol Webb | Yönetim kurulu üyesi | 07 Kasım 2024 A | 11.835 | 0 | 0 | $0 |
| Suren G Dutia | Yönetim kurulu üyesi | 07 Kasım 2024 A | · | 0 | 0 | $0 |
| Dennis M Mcgrath | Yönetim kurulu üyesi | 07 Kasım 2024 A | · | 0 | 0 | $0 |
| William Kane | Yönetim kurulu üyesi | 04 Ekim 2022 A | · | 0 | 0 | $0 |
| Howard Safir | Yönetim kurulu üyesi | 04 Ekim 2022 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 197.364 SH | 19 Ağustos 2026 | Günlük |
CTXR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$4.00
+652,4%
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-10-02Ortalama hedef $4.00 +652,4%
Düşük$4.00
Ortalama$4.00
Yüksek$4.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CTXR | · | -0.4 | · | · | · | · |
| RKTO | · | · | · | · | · | · |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | · |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | · |
| TVRD | $40M | -1.3 | -66.0% | · | -67.6% | · |
| BFRI | · | · | · | · | · | · |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| CALC | · | -3.3 | -29.7% | · | · | · |
| KPRX | $7M | -0.7 | · | · | -56.6% | · |
| ADIL | $244.4K | -0.0 | · | · | -146.8% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026